Results from a recent study published in Nature show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.
In its report concerning federally-sponsored research involving human volunteers, the Commission concluded that current rules and regulations provide adequate safeguards to mitigate risk.
A new study shows that starting antiretroviral therapy (ART) soon after beginning tuberculosis treatment can significantly reduce the onset of new AIDS-defining illness and death in those with advanced HIV.
